Inventor

NORMIER GERARD

14 patents

⚠️ This page may combine multiple inventors who share the name “NORMIER GERARD”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

FABRE SA PIERRE

9 patents

US4460575AJul 17, 1984

Method of preparing immunostimulant proteoglycans which induce production of interferon, proteoglycans obtained and pharmaceutical compositions containing them

FABRE SA PIERRE8 citations72

US4397838AAug 9, 1983

Preparations of purified bacterial membranal proteoglycans

FABRE SA PIERRE13 citations72

US4389396AJun 21, 1983

Immunostimulating preparations based on ribosomal RNA's and a process for the preparation of the RNA's

FABRE SA PIERRE8 citations72

US4314994AFeb 9, 1982

Process for obtaining a plasminogen activator

FABRE SA PIERRE15 citations72

US4297272AOct 27, 1981

Process for the preparation of purified bacterial membranal proteoglycans

FABRE SA PIERRE12 citations72

US4349540ASep 14, 1982

Process for preparing vaccines based on antigenic ribosomal fractions

FABRE SA PIERRE8 citations70

PF MEDICAMENT

5 patents

US4933440AJun 12, 1990

Immunomodulators obtained semisynthetically from a bacterial polysaccharide isolated from a non-encapsulated mutant strain of Klebsiella pneumoniae

PF MEDICAMENT10 citations72

US4734403AMar 29, 1988

Membrane polysaccharides which are useful as immunostimulants

PF MEDICAMENT10 citations72

US4937327AJun 26, 1990

Derivative of D.25, process for its preparation, its use as an immunostimulant, and pharmaceutical compositions containing the derivative

PF MEDICAMENT4 citations61

US5601799AFeb 11, 1997

Partially delipidated D25 polysaccaride composition for imaging and diagnosis

PF MEDICAMENT4 citations55

US5362474ANov 8, 1994

Method for detecting and locating inflammatory or tumor foci in a patient and diagnostic kit therefor

PF MEDICAMENT1 citations50

NORMIER GERARD

FABRE SA PIERRE

Vaccinal complex containing a specific antigen and vaccine containing it

Process for obtaining a plasminogen activator

Plasminogen activator pharmaceutical compositions

Method of preparing immunostimulant proteoglycans which induce production of interferon, proteoglycans obtained and pharmaceutical compositions containing them

Preparations of purified bacterial membranal proteoglycans

Immunostimulating preparations based on ribosomal RNA&#39;s and a process for the preparation of the RNA&#39;s

Process for obtaining a plasminogen activator

Process for the preparation of purified bacterial membranal proteoglycans

Process for preparing vaccines based on antigenic ribosomal fractions

PF MEDICAMENT

Immunomodulators obtained semisynthetically from a bacterial polysaccharide isolated from a non-encapsulated mutant strain of Klebsiella pneumoniae

Membrane polysaccharides which are useful as immunostimulants

Derivative of D.25, process for its preparation, its use as an immunostimulant, and pharmaceutical compositions containing the derivative

Partially delipidated D25 polysaccaride composition for imaging and diagnosis

Method for detecting and locating inflammatory or tumor foci in a patient and diagnostic kit therefor

Immunostimulating preparations based on ribosomal RNA's and a process for the preparation of the RNA's